title: Study of the scientific production on leishmaniasis in Latin America.
abstract: Leishmaniasis is a highly relevant neglected tropical disease. It has important consequences in affected populations, including a high fatality rate in its visceral form. It is present in Latin America, then it is necessary to promote more research on it. A bibliometric assessment of the Latin American scientific production in leishmaniasis was done.
  
  
  METHODS
  Bibliometric study at SCI (1980-2013), MEDLINE/GOPUBMED (1802-2013), Scopus (1959-2013), SCIELO (2004-2013), LILACS (1980-2013). Different study types, characterized by years, city/country of origin, journals and more productive authors, by country, cites and H index.
  
  
  RESULTS
  At SCI, 2857 articles were found (17.7% of the total). Brazil was the highest producer (58.1%), followed by Colombia (9.9%) and Venezuela (5.6%); the region received 41186 citations, 54.2% of Brazil (H index=62), 12.1% Colombia (H index=30) and 4.5% of Venezuela (H index=25). At Scopus, there are 3681 (14.7% of the total), 53.2% Brazil, 6.8% Colombia and 6.0% Venezuela; 38.46% at Brazil were from Fundação Oswaldo Cruz; 30.6% of Colombia corresponded to Universidad de Antioquia; 31.34% at Venezuela were from Universidad Central de Venezuela. At Medline there are 4525 records (60.6% of Brazil). At SciELO there are 1068 records (67.5% Brazil). At LILACS, there are 1740 records (56.0% Brazil).
  
  
  CONCLUSIONS
  Scientific production of Brazil predominates in the region, with one single institution generating more articles than Colombia and Venezuela together. Scientific production in bibliographical data bases, particularly regional, is still relatively low, and the disease neglected when compared to other tropical conditions such as dengue and malaria.
authors: Yuliana
authors: Y
authors: Perilla-Gonzalez
authors: Daniela
authors: D
authors: Gomez-Suta
authors: Nathalia
authors: N
authors: Delgado-Osorio
authors: Natalia
authors: N
authors: Hurtado-Hurtado
authors: Juan D
authors: JD
authors: Baquero-Rodriguez
authors: Andres F
authors: AF
authors: Lopez-Isaza
authors: Guillermo J
authors: GJ
authors: Lagos-Grisales
authors: Soraya
authors: S
authors: Villegas
authors: Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia. arodriguezm@utp.edu.co.
authors: Alfonso J
authors: AJ
authors: Rodriguez-Morales
mesh_terms: D000981:Antiprotozoal Agents / Q000627:therapeutic use; D015706:Bibliometrics; D035843:Biomedical Research / Q000706:statistics & numerical data*; D006801:Humans; D055552:Infectious Disease Medicine / Q000706:statistics & numerical data*; D007891:Leishmania / Q000187:drug effects / Q000472:pathogenicity; D007896:Leishmaniasis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology / Q000517:prevention & control; D054332:Leishmaniasis Vaccines / Q000627:therapeutic use; D058069:Neglected Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000469:parasitology / Q000517:prevention & control; D011379:Prognosis; D039781:PubMed; D012307:Risk Factors
chemical_list: D000981:Antiprotozoal Agents; D054332:Leishmaniasis Vaccines